Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06208761
Other study ID # IRB1-050/2566
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date May 9, 2023
Est. completion date November 6, 2023

Study information

Verified date January 2024
Source Burapha University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

One hundred and forty-one male and female participants aged 18-59 years were randomly divided into 4 groups: 1) control group: neither received exercise program nor supplement but received placebo capsule for 8 weeks 2) experiment-1: received Triphala capsule at 1,000 mg/day, before breakfast for 500 mg and before dinner for 500 mg, for consecutive 5 days/week for 8 weeks 3) experiment-2: received leg cycling exercise program in the form of high-intensity interval training (HIIT) for 28 min/day, 3 days/week for 8 weeks and 4) experiment-3: received both Triphala capsule and HIIT in the similar extent to the experiment-1 and experiment-2 groups for 8 weeks. Immune system function and oxidative stress including blood interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), malondialdehyde (MDA), and protein carbonyls levels were analyzed. In addition, blood alanine aminotransferase (ALT) enzyme and creatinine levels were also analyzed for determining liver and kidney toxicity, particularly in the Triphala supplementation and combined Triphala supplementation and HIIT groups.


Description:

This study aimed to investigate and compare immune system function and oxidative stress before and after supplementation with Triphala and high-intensity interval training in individuals with post COVID-19. One hundred and forty-one male and female participants aged 18-59 years were randomly divided into 4 groups: 1) control group: neither received exercise program nor supplement but received placebo capsule for 8 weeks 2) experiment-1: received Triphala capsule at 1,000 mg/day, before breakfast for 500 mg and before dinner for 500 mg, for consecutive 5 days/week for 8 weeks 3) experiment-2: received leg cycling exercise program in the form of high-intensity interval training (HIIT) for 28 min/day, 3 days/week for 8 weeks and 4) experiment-3: received both Triphala capsule and HIIT in the similar extent to the experiment-1 and experiment-2 groups for 8 weeks. Immune system function and oxidative stress including blood interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), malondialdehyde (MDA), and protein carbonyls levels were analyzed. In addition, blood alanine aminotransferase (ALT) enzyme and creatinine levels were also analyzed for determining liver and kidney toxicity, particularly in the Triphala supplementation and combined Triphala supplementation and HIIT groups. Results showed that levels of IFN-gamma, TNF-alpha, MDA, and protein carbonyls before 8-week program were not different among 4 groups. After the program the levels of IFN-gamma, TNF-alpha, MDA, and protein carbonyls were significantly decreased in the Triphala supplementation, HIIT, and combined Triphala supplementation and HIIT groups (all p < 0.05). However, there were no significant differences between groups. Besides, levels of ALT enzyme and creatinine were not different among the 4 groups both before and after the 8-week program. There were also no significant differences between groups. This study concluded that in individuals with post COVID-19, Triphala supplementation at 1,000 mg/day, 5 days/week for consecutive 8 weeks can improve immune system function and alleviate oxidative stress. These outcomes are similar to those of HIIT and combined Triphala supplementation and HIIT interventions. However, prolonged investigation periods may help observing differences between interventions.


Recruitment information / eligibility

Status Completed
Enrollment 141
Est. completion date November 6, 2023
Est. primary completion date October 22, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 59 Years
Eligibility Inclusion Criteria: - Passed COVID-19 infection for at least 4 weeks with a symptom of long COVID including regular fatigue, headache, inability to concentrate, hair loss, and dyspnea (the symptom was exacerbated by exercise or concentration) - Aged between 18 to 59 years - Normal body mass index (BMI 18.5 to 24.9 kg/m2) Exclusion Criteria: - Regular exerciser (>2 times per week or >150 min per week) - Regular intake of dietary supplements, i.e., vitamins, antioxidants, herbs - Regular smokers or alcohol drinkers (>2 times per week) - Food allergy, especially herbs i.e., emblic myrobalan, chebulic myrobalan, beleric myrobalan - Hypertension, diabetes, cardiovascular disease, respiratory disease, endocrine disease, neuromuscular disease, musculoskeletal disease, liver disease, renal disease, immune disease, infectious disease, or cancer - Current signs or symptoms of infection, i.e., fever, hyperpnea, dyspnea, and palpitations

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Triphala capsule supplementation and high-intensity interval training
Triphala capsule supplementation is categorized in dietary supplement but and high-intensity interval training is included as other

Locations

Country Name City State
Thailand Faculty of Allied Health Sciences, Burapha University Mueang ChonBuri

Sponsors (1)

Lead Sponsor Collaborator
Burapha University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concentration of interferon-gamma Concentration of interferon-gamma was measured in serum in pg (picogram)/mL unit Before and after 8 weeks
Primary Concentration of tumor necrosis factor-alpha Concentration of tumor necrosis factor-alpha was measured in serum in pg (picogram)/mL unit Before and after 8 weeks
Primary Concentration of blood malondialdehyde Concentration of malondialdehyde was measured in plasma in uM (micromolar) unit Before and after 8 weeks
Primary Concentration of blood protein carbonyl Concentration of protein carbonyl was measured in plasma in nmol/mg protein unit Before and after 8 weeks
Secondary Concentration of blood alanine aminotransferase enzyme Concentration of alanine aminotransferase enzyme was measured in serum in U/L unit Before and after 8 weeks
Secondary Concentration of blood creatinine Concentration of creatinine was measured in serum in mg/dL unit Before and after 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05945641 - Effect of Low-load Resistance Training vs. High-intensity Interval Training on Local Muscle Endurance N/A
Completed NCT04084535 - Effects of High Intensity Interval Training (HIIT) vs. Inspiratory Muscle Training on the Recovery After a Maximal Apnea. N/A
Completed NCT06262256 - Effects of High-intensity Interval Training on Myocardial Strain in Metabolic Syndrome Patients N/A
Completed NCT03473990 - Short-term, Home-based, High-intensity Interval Training (HIT) for Improving Fitness N/A
Completed NCT04277091 - Upper-body High-intensity Interval Training and Mixed Meal Responses N/A
Recruiting NCT06108986 - Tabata vs Plyometric Training on Range of Motion, Agility and Vertical Jump in Taekwondo Players N/A
Recruiting NCT05562414 - Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis N/A
Completed NCT02759432 - Effect of a 4-week Fun Fast Interval Training (FFIT) Activity Programme on Physical Fitness and Quality of Life in Adolescent School Pupils N/A
Completed NCT05988606 - Work Rate Adjustments During a High-intensity Interval Training on a Stationary Bike in a Hot and Temperate Environment N/A
Completed NCT05274542 - Acute Effect of Blood Flow Restricted High-Intensity Resistive Training N/A
Completed NCT03563456 - Development of Structured Exercise Program for T2DM Management N/A
Completed NCT04033523 - High-Intensity Interval Training Recuperates Capacity of Endogenous Thrombin Generation in Patients With Heart Failure N/A
Completed NCT03759951 - Hybrid Exercise Training for Health, Performance and Well-Being (DoIT II) N/A
Completed NCT03570424 - Whey Protein Support to Metabolic and Performance Adaptations in Response HIIT N/A
Completed NCT02626767 - Effect of Novel High-intensity Interval Training on Health and Fitness Outcomes in English Adolescents N/A
Completed NCT03159494 - High-intensity Training, Self-monitoring and Diabetes 2 N/A
Recruiting NCT05838950 - HIIT Effects on Cardiometabolic Health N/A
Completed NCT05513521 - Speed-specific Training and Ultrasound N/A
Recruiting NCT03593746 - Effects of High Intensity Interval Training and Combined Training in Type 2 Diabetic (T2D) Patients N/A
Completed NCT03467594 - BE@Work: Brief Exercise at Work N/A